AUTHORS

Real Money authors - MoneyShow.com

MoneyShow.com

MoneyShow is a global financial-media company that operates the world's leading investment and trading conferences. Each show brings together thousands of investors to attend workshops, presentations and seminars given by the nation's top financial experts. The company also offers exclusive seminars-at-sea, with the investment industry's leading partners. In addition, MoneyShow operates the award-winning multimedia online community MoneyShow.com and publishes free investing and trading newsletters, which provide individual investors and active traders with exclusive ongoing access to the latest investment and trading ideas from the nation's most respected and trusted financial experts.

Email MoneyShow.com

Recent Articles By The Author

5 Reasons to Bet on Biotech

Small-cap biotech names are seeing dramatic, widespread declines, creating a liquidation sale for investors.

7 Stocks to Energize Your Portfolio

Many strong, cheap energy names are also still well below pre-pandemic levels.

5 Ways to Profit From Payments, Payroll and Processing

Several contributors see upside potential in various niches within the fintech sector.

7 Ways to Invest in the Future of Cannabis

Leading advisors pick four favorite cannabis purveyors, two marijuana ETFs and one ancillary tobacco segment firm.

The 25 Best Buys in Clean Energy

These renewable energy favorites include nuclear, hydrogen, wind, and solar stocks, among others.

Ride in the Fast Lane With These 6 Auto Stocks

The article covers 6 stocks involved in auto manufacturing and sales.

9 Energy Stock Picks to Pump Up Your Portfolio

The energy sector has been a top performer.

Dow Theory's Top 15 Utilities Portfolio

This portfolio has returned 305.6% since its inception in 2007.

Rev Up Your Portfolio With These 5 Auto Parts Stocks

These names are plays on the complexity of new cars, problems in the global supply chain and current strong demand for used cars.

Clinically Speaking: 6 Stocks Behind the Scenes at Drug Trials

Investors are increasingly looking to the companies involved in clinical trials. Here are six favorite names in this space.

Email sent

Thank you, your email to has been sent successfully.

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight